• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Poniard Pharmaceuticals Inc

+ Add to Watchlist

NX1B:GR

0.150 EUR 0.0000.00%

As of 02:16:04 ET on 09/23/2014.

Snapshot for Poniard Pharmaceuticals Inc (NX1B)

Open: 0.150 Day's Range: 0.150 - 0.150 Volume: 0
Previous Close: 0.150 52wk Range: 0.100 - 0.360 1-Yr Rtn: -25.00%

Stock Chart for NX1B

No chart data available.
  • NX1B:GR 0.150
  • 1D
  • 1M
  • 1Y
0.150
Interactive NX1B Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NX1B

Current P/E Ratio (ttm) -
Estimated P/E(12/2011) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2011) -
Est. PEG Ratio -
Market Cap (M EUR) 0.22
Shares Outstanding (M) 1.50
30 Day Average Volume 21
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NX1B

No data available

Company Profile & Key Executives for NX1B

Poniard Pharmaceuticals, Inc. develops drugs used to treat cancer.

Cheni KwokVP:Business DevelopmentLinda T FindlayVP:Human Resources
More Company Profile & Key Executives for NX1B

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil